Evaluating the Efficacy of EGFR-TKIs Combined With Radiotherapy in Advanced Lung Adenocarcinoma Patients With EGFR Mutation: A Retrospective Study

Objective: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been recommended as the first-line treatment for advanced lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation. This study retrospectively evaluated patients’ survival and related prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuxiang, Yu, Wenjuan, Shi, Jian, Qiu, Rong, Jiang, Nan, Wang, Zhuofan, Yang, Jie, Jia, Zhongfei, Song, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134423/
https://www.ncbi.nlm.nih.gov/pubmed/35607295
http://dx.doi.org/10.1177/15330338221100358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134423/
https://www.ncbi.nlm.nih.gov/pubmed/35607295
http://dx.doi.org/10.1177/15330338221100358

Ejemplares similares